Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases. Geertsema S, Otten AT, Bouwknegt DG, Visschedijk MC, et al. Inflamm Bowel Dis 2023;29:e10-e11.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Geertsema S, Otten AT, Bouwknegt DG, Visschedijk MC, et al. Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2023;29:e10-e11.
PMID: 36762763